AI-generated summary
The authors compared an individualized endobronchial photodynamic therapy method, guided by fluorescence measurement of photosensitizer accumulation in tumor tissue, with a standard method in two randomized groups of 45 patients each with central non-small cell lung carcinoma. They report that the individualized method significantly shortened irradiation time while treatment results were the same, and it identified patients without tumor fluorescence for whom therapy was judged unreasonable.
- Who or what was studied
- Patients with central non-small cell carcinoma of the lung, 45 per group in two randomized groups
- Limits stated in the abstract
- The abstract does not state the wavelength used, long-term outcomes, or the specific measures of treatment results beyond the reported irradiation time.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.